The tariff classification of blood monitoring meters from South Korea
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated June 11, 2025, on behalf of your client, Coagusense, Inc., you requested a tariff classification ruling. Descriptive literature was provided for our review. The first three items under consideration are described as high-accuracy prothrombin time/international normalized ratio (PT/INR) test meters (model numbers PT2 PT/INR Monitoring Meter PST, PT2 PT/INR Monitoring Meter Pro, and PT3 PT/INR Monitoring Meter PST).
The devices are primarily designed for home and laboratory use, allowing patients with chronic cardiovascular or thromboembolic conditions requiring anticoagulant therapy to monitor their PT/INR levels.
The PT/INR meters are available by prescription only and designed for persons with particular diagnoses, including unspecified, chronic, paroxysmal, or persistent atrial fibrillation, acute deep vein embolism and thrombosis, coagulation defects, presence of a prosthetic heart valve, and other conditions which require the long-term use of anticoagulant medications. The meters are all very similar with only a few defining characteristics.
The PT2 PRO (Professional) meter is intended for use by healthcare professionals in various settings such as hospitals, doctor’s offices, and laboratories. The PT2 PST (Patient Self Testing) and PT3 PST meters are intended for use by the patient directly. After testing, the patient provides the test results to their healthcare provider, who in turn uses the test results to manage the patient’s anticoagulation medication. The PT2 PRO and PT2 PST models operate under the same platform and technology.
The user interface differs depending on whether it is intended for use by professionals (PRO) or for patient self-testing (PST). The PT2 and PT3 meters are distinguished by their functionality and user interface. The PT2 meter can transfer testing data using Bluetooth, Wi-Fi, or a wired connection, while the PT3 meter can transfer data by Bluetooth only. In addition, the PT2 meter displays prompts using words with explanations, while the PT3 meter uses an icon-based display resembling apps on a smartphone.
The devices are imported with the user manual, quick reference guide, and power supply. The meters feature a user-friendly color touchscreen with displayed instructions to guide users through the testing process. The fourth item under consideration is the PT/INR Professional Monitoring Meter Kit (Assure PT Care), which is a device that operates similarly to the PT2 PT/INR Monitoring Meter Pro but also includes additional components.
The kit is imported with the meter, user manual, quick reference guide, testing tips guide, power supply, a sample pack of lancets, sample transfer tubes, a stylus pen, and a carrying case. The PT/INR meters function by measuring the clotting time of a fresh capillary whole blood sample applied to a test strip, which is read by the meter to electronically measure the time it takes for blood to clot.
The user inserts into the PT/INR meter a single-use test strip which contains thromboplastin, a reagent that triggers the natural process by which blood begins to clot.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N350072).